METASTATIC SKIN SQUAMOUS CELL CARCINOMA
Clinical trials for METASTATIC SKIN SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SKIN SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC SKIN SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for transplant patients with advanced skin cancer: immune drugs may control tumors without losing the kidney
Disease control OngoingThis early-phase study tests whether combining immune-boosting drugs (nivolumab and ipilimumab) with a transplant-protecting drug (tacrolimus) can shrink or control advanced skin cancers in kidney transplant recipients. The goal is to treat the cancer while keeping the donated ki…
Matched conditions: METASTATIC SKIN SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for rare cancers: immune-boosting drug shows promise
Disease control OngoingThis study tests a drug called pembrolizumab in 157 people with rare tumors that cannot be removed by surgery or have spread. The drug helps the immune system fight cancer by blocking a protein that slows it down. The main goal is to see if the drug can stop tumors from growing f…
Matched conditions: METASTATIC SKIN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 24, 2026 16:07 UTC